Orthofix Medical, Inc. (OFIX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BioLife Solutions, Inc.

IRadimed Corp.

Artivion, Inc.

Mesa Laboratories, Inc.

Orthofix Medical, Inc.

Outset Medical, Inc.

Silk Road Medical, Inc.

Atrion Corp.

Cytek Biosciences, Inc.

Nevro Corp.

Minerva Surgical, Inc.

Why is Orthofix Medical, Inc. ?

Positive results in Mar 26

OPERATING CASH FLOW(Y) Highest at USD 35.17 MM
ROCE(HY) Highest at -13.43%
RAW MATERIAL COST(Y) Fallen by -30.75% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -8.70%, its profits have risen by 21.2%

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -8.70% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Orthofix Medical, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Orthofix Medical, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Orthofix Medical, Inc.

-8.7%

-0.66

41.46%

S&P 500

25.41%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.13%

EBIT Growth (5y)

-238.62%

EBIT to Interest (avg)

-11.48

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.22

Sales to Capital Employed (avg)

1.20

Tax Ratio

1.58%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.03

EV to EBIT

-6.51

EV to EBITDA

-102.52

EV to Capital Employed

1.02

EV to Sales

0.65

PEG Ratio

Dividend Yield

ROCE (Latest)

-15.69%

ROE (Latest)

-20.74%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 35.17 MM

ROCE(HY)

Highest at -13.43%

RAW MATERIAL COST(Y)

Fallen by -30.75% (YoY

CASH AND EQV(HY)

Highest at USD 205.99 MM

PRE-TAX PROFIT(Q)

At USD -20.08 MM has Grown at 61.92%

NET PROFIT(Q)

At USD -20.16 MM has Grown at 62.46%

-6What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 32.49 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 6.12 times

INTEREST(Q)

Highest at USD 5.66 MM

Here's what is working for Orthofix Medical, Inc.

Operating Cash Flow

Highest at USD 35.17 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Pre-Tax Profit

At USD -20.08 MM has Grown at 61.92%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -20.16 MM has Grown at 62.46%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Cash and Eqv

Highest at USD 205.99 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -30.75% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Orthofix Medical, Inc.

Interest

At USD 5.66 MM has Grown at 30.18%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 32.49 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at USD 5.66 MM

in the last five periods and Increased by 30.18% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debtors Turnover Ratio

Lowest at 6.12 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio